Antibodies against insulin-like growth factor I receptor and uses thereof

Details for Australian Patent Application No. 2007338402 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Poehling, Sylke; Kuenkele, Klaus-Peter; Moser, Samuel; Koll, Hans

Agent Davies Collison Cave

Pub. Number AU-A-2007338402

PCT Pub. Number WO2008/077546

Priority 06026651.7 22.12.06 EP

Filing date 19 December 2007

Wipo publication date 3 July 2008

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

C12N 5/12 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Fused cells, e.g. hybridomas

Event Publications

18 June 2009 PCT application entered the National Phase

  PCT publication WO2008/077546 Priority application(s): WO2008/077546

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007338403-shRNA-mediated inhibition of expression of alpha-1. 6-fucosyltransferase

2007338385-Synergistic therapeutic use of prothrombin complex concentrates with FVIII concentrates